Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
In the Phase 2 obesity trial published in NEJM in 2023, retatrutide at the 12 mg weekly dose produced a mean placebo-adjusted body weight reduction of 22.1 percentage points (22.1% (24.2% arm) mean absolute reduction on the retatrutide arm) at 48 weeks (Jastreboff et al., NEJM, 2023)
Once theyve met their goals, many people move to a maintenance dose or continue with lifestyle changes alone
semaglutide, or Ozempic
Sawicka 2020) Common, mild to moderate AEs A 10-year follow-up (n=83) evaluation reported common AEs including fish odour, abdominal pain, diarrhoea, reflux, flatulence, low stamina (ungraded
doi:10.1007/s00125-002-0878-6 37
US$ 28.63
US$ 27.38
US$ 24.59
US$ 23.99
